Atlas Trials

Pembrolizumab in Treating Patients With Stage IB-IV Mycosis Fungoides

Clinical trial NCT03695471 · COMPLETED

Trial details

NCT number
NCT03695471
Sponsor
Mayo Clinic
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Mycosis FungoidesSezary SyndromeStage IB Mycosis Fungoides and Sezary Syndrome AJCC v8Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v8Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v8Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v8Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v8Stage IVA1 Mycosis Fungoides and Sezary Syndrome AJCC v8Stage IVA2 Mycosis Fungoides and Sezary Syndrome AJCC v8
Start date
2020-02-04
Primary completion
2023-06-21
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.